510(k) device
Ind One Step Occult Blood (Fob) Test
Ind Diagnostics, Inc. · Reagent, Occult Blood (KHE, Class II) · First FDA decision Dec 19, 2012, newest Dec 19, 2012Colorectal cancer and polypsGastrointestinal bleeding
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
285
Naming "One Step"
MAUDE reports
0
Brand "One Step", since 2015
PubMed studies
50,629
Mentioning "One Step"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ind One Step Occult Blood (Fob) Test
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Fecal Occult Blood TestNational determinationOn the books190.34Updated Oct 1, 2026
- Screening Immunoassay Fecal-Occult Blood TestNational analysisReview closedCAG-00180NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "One Step", any status and sponsor, newest update first.
- Accelerated Optimization of Foundational Medical Therapy in Acute Decompensation of Heart Failure by Telemonitoring: A Pragmatic Multi-center Randomized and Cost-Effectiveness StudyPivotal-lookingRecruiting
Chinese University of Hong KongAcademic, hospital or other
NCT07016815 · 126 participants (planned) · Start Jan 1, 2027 · Primary completion Dec 1, 2028
Device: Wearable wrist heart rate and activity monitor; Bluetooth enabled body weight scale with bioimpedance analysis and 2 more · For: Acute Heart Failure With Reduced Left Ventricular Ejection Fraction
Sites: Hong Kong, Hong Kong · 8 sites in all
- Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart FailurePivotal-lookingNot yet recruiting
University of MichiganAcademic, hospital or other
NCT07946679 · 600 participants (planned) · Start Dec 2026 · Primary completion Dec 2031
Device: Cellular-connected remote patient monitoring · For: Heart Failure; Heart Failure Hospitalization
Sites: Ann Arbor, Michigan; Plano, Texas
- The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health CarePivotal-lookingActive, not recruiting
Summit Institute for Development, IndonesiaAcademic, hospital or other
NCT07842224 · 10,800 participants (planned) · Start Oct 22, 2026 · Primary completion May 2027
Device: Digitally Enabled District (DED) · For: Digital Health; Maternal Health Services; Prenatal Care and 2 more
Sites: Mataram, Indonesia
282 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "One Step", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KHE
30 reports: 27 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "One Step"[tiab]. The summary above synthesizes these.
- Practical Advice on the One-Step Growth Curve.
Kropinski AM · Methods Mol Biol · 2018
- One step...backwards.
del Piñal F · Br J Plast Surg · 2004Comment, Letter
- One-Step Antibody Arrays.
Mao YQ, Li LH · Methods Mol Biol · 2021
- TRexit is going one step further.
Miano R, Manenti G, Orecchia L · Prostate Cancer Prostatic Dis · 2024Editorial
- Two Steps Forward, One Step Back.
Diacon AH · N Engl J Med · 2022Editorial, Comment
- One Step Forward, Two Steps.
Goldstone SE · Dis Colon Rectum · 2018Editorial, Comment
- One step forward to personalized medicine?
Dodge HH, Arnold SE · Alzheimers Dement (N Y) · 2023Editorial
- Overcoming inertia one step at a time.
Stukus DR · Ann Allergy Asthma Immunol · 2023Editorial
- One Step Forward in Opportunistic Screening for Body Composition.
Tong A, Magudia K · Radiology · 2023Editorial, Comment
- One Step Forward.
Shue BK · J Calif Dent Assoc · 2015Editorial
- One step at a time.
Schoemans H, Ljungman P · Blood · 2021Editorial, Comment
- Inpatient Mobility Technicians: One Step Forward?
Young DL, Brotman DJ, Hoyer EH · J Hosp Med · 2019Editorial
Other devices of this type
Also filed under product code KHE.
- Instant-View Fecal Occult Blood (Fob) Rapid TestAlfa Scientific Designs, Inc. · 510(k) 2007
- Instant-view-PLUS immunochemical Fecal Occult Blood TestAlfa Scientific Designs, Inc. · 510(k) 2018
- InSure ONEEnterix, Inc. · 510(k) 2017
- hema-screen SPECIFIC GoldImmunostics Inc. · 510(k) 2017
- Wondfo One Step Fecal Occult Blood (FOB) TestGuangzhou Wondfo Biotech Co., Ltd. · 510(k) 2017
- hema-screen ER XCEL Enhanced Readability Fecal Occult Blood TestImmunostics Inc. · 510(k) 2017
- OC-Light S FITEiken Chemical Co., Ltd. · 510(k) 2015
- Osom Ifob 25 Test and Patient Collection Kit Osom Ifob Control Kit Osom Ifob 50 Test KitSEKISUI Diagnostics, LLC · 510(k) 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.